Fourth quarter 2025 revenue of $209.8 million was consistent with fourth quarter 2024 revenue, but grew 4% year-over-year ...

Gilead Sciences has shored up its position in cell therapies for cancer with a deal to acquire Arcellx, a company it has been ...

Ellis Bio, a developer of next-generation epigenomics technologies, today announced the official commercial launch of its SuperMethyl™ Max Bisulfite Conversion Kit, a new and gentle methyl conversion ...

40% increase in output to 35 billion reads, up to Q70 quality scores, improved turnaround time, and staggered starts are ...

Reducing Uncertainty in the Care and Treatment of Blood Cancer ST. LOUIS, MO, UNITED STATES, February 23, 2026 ...

Guardant Health is a leader in liquid biopsy. It has market-leading platforms in tumor genomic profiling, molecular residual disease, or MRD, testing, and colorectal cancer screening. Although these ...

Guwahati: The upcoming ‘Maharaj Prithu’ flyover, which is over 5 kilometres long and connects the Ambari area to Bamunimaidam along the MRD Road, will be inaugurated on March 10, CM Himanta Biswa ...

On February 6, 2026, TD Cowen upgraded Adaptive Biotechnologies Corporation (NASDAQ:ADPT)’s price target to $21 from $20 ...

The organization presented data aggregated from multiple clinical trials to explore ctDNA's potential as a surrogate endpoint predictive of treatment benefit in lung and other cancers.

A publicly available AI tool correctly predicted approximately twice as many children with acute lymphoblastic leukemia who ...

Cancer researchers are making strides in efforts to use genetic profiling to develop a more precise understanding of the ...